Insider buying, week of October 19, 2026
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 79 | RAPP | Rapport Therapeutics, Inc. | Ignelzi Troy A. | CFO | 2026-10-21 | $144K | 55% | 6 insiders |
| 75 | RAPP | Rapport Therapeutics, Inc. | Paul Steven M | Director | 2026-10-22 | $974K | 86% | 6 insiders |
| 67 | NXG | NXG NextGen Infrastructure Income Fund | Nelson Blake | CFO | 2026-10-23 | $40K | 86% | 3 insiders |
| 66 | RAPP | Rapport Therapeutics, Inc. | Maraganore John | Director | 2026-10-22 | $217K | new | 6 insiders |
| 65 | DX | DYNEX CAPITAL INC | Popenoe Smriti Laxman | CEO | 2026-10-20 | $50K | new | 3 insiders |
| 64 | RAPP | Rapport Therapeutics, Inc. | Silva Paul M | Director | 2026-10-22 | $100K | new | 6 insiders |
| 64 | RAPP | Rapport Therapeutics, Inc. | Young Wendy B. | Director | 2026-10-22 | $100K | 40% | 6 insiders |
| 64 | RAPP | Rapport Therapeutics, Inc. | Sanchez Ramiro | Director | 2026-10-23 | $98K | new | 6 insiders |
| 58 | DX | DYNEX CAPITAL INC | Popenoe Smriti Laxman | CEO | 2026-10-20 | $106K | 2% | 3 insiders |
| 57 | DX | DYNEX CAPITAL INC | Boston Byron L | CEO | 2026-10-20 | $100K | 1% | 3 insiders |
| 57 | - | Blackstone Private Real Estate Credit & Income Fund | Blackstone Private Multi-Asset Credit & Income Fund / Blackstone Private Credit Strategies Llc / Blackstone Intermediary Holdco L.L.C. / Blackstone Securities Partners L.P. / Blackstone Advisory Servi | 10% Owner | 2026-10-21 | $726K | 94% | 2 insiders |
| 57 | - | Blackstone Private Real Estate Credit & Income Fund | Blackstone Holdings Iv L.P. / Blackstone Holdings Iv Gp L.P. / Blackstone Holdings Iv Gp Management (Delaware) L.P. / Blackstone Holdings Iv Gp Management L.L.C. / Blackstone Holdings I L.P. / Blackst | 10% Owner | 2026-10-21 | $726K | 94% | 2 insiders |
Source: SEC Form 4 filings. Score is a data signal, not a recommendation. Not investment advice.